EC Healthcare
UNHLF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $248 | $2,077 | $2,063 | $2,090 |
| % Growth | -88.1% | 0.7% | -1.3% | – |
| Cost of Goods Sold | $205 | $1,506 | $1,384 | $1,423 |
| Gross Profit | $43 | $572 | $678 | $666 |
| % Margin | 17.3% | 27.5% | 32.9% | 31.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $128 | $127 | $111 |
| SG&A Expenses | $38 | $291 | $305 | $299 |
| Sales & Mktg Exp. | $0 | $85 | $93 | $100 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $38 | $291 | $305 | $638 |
| Operating Income | $5 | -$278 | $373 | $47 |
| % Margin | 2% | -13.4% | 18.1% | 2.3% |
| Other Income/Exp. Net | -$3 | $121 | -$317 | -$66 |
| Pre-Tax Income | $2 | -$158 | $57 | -$18 |
| Tax Expense | $1 | -$6 | $16 | $13 |
| Net Income | -$1 | -$181 | $14 | -$26 |
| % Margin | -0.5% | -8.7% | 0.7% | -1.2% |
| EPS | -0.001 | -0.15 | 0.012 | -0.022 |
| % Growth | 99.3% | -1,360.5% | 154.1% | – |
| EPS Diluted | -0.001 | -0.15 | 0.012 | -0.022 |
| Weighted Avg Shares Out | 1,185 | 1,185 | 1,185 | 1,164 |
| Weighted Avg Shares Out Dil | 1,185 | 1,185 | 1,185 | 1,185 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $26 |
| Interest Expense | $5 | $48 | $42 | $123 |
| Depreciation & Amortization | $34 | $184 | $150 | $148 |
| EBITDA | $40 | $128 | $234 | $252 |
| % Margin | 16.3% | 6.1% | 11.3% | 12.1% |